Full-Time

Manufacturing Shift Supervisor

Production

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

Compensation Overview

$71k - $88.4k/yr

Rensselaer, NY, USA

In Person

Category
Manufacturing & Production Operations
Required Skills
Quality Assurance (QA)

Get referred to Curia

See people who can refer or advise you

Requirements
  • Five to ten years of manufacturing experience.
  • Knowledge of standard operating procedures.
  • Ability to demonstrate leadership and communication skills.
  • Must pass a background check.
  • Must pass a drug screen.
  • May be required to pass occupational health screening.
Responsibilities
  • Manage all activities of Chemist Operators on the shift to manufacture active pharmaceutical ingredients according to issued batch records and perform daily housekeeping actions.
  • Keep Production staff and managers informed of shift progress and activities.
  • Prepare pass-off sheets for shift changes and communicate procedural changes and pertinent information to the next shift.
  • Provide the Manager with a summary of daily activities and shift progress.
  • Oversee cleaning of production equipment and the facility in accordance with standard operating procedures and current Good Manufacturing Practice guidelines.
  • Enforce safety procedures and guidelines in accordance with company standard operating procedures and Occupational Safety and Health Administration standards.
  • Train and coach Chemist Operators in new procedures and policies.
  • Act as an extension of Quality Assurance in auditing functions, including daily evaluation and auditing of current batch records in progress for the current and previous shifts.
  • Conduct daily facility walkthrough audits to identify and correct errors, eliminate problems, or bring them to upper management's attention.
  • Enable and enact changes to Good Manufacturing Practice problems identified in the facility, such as clutter in hallways and inventory problems.
  • Follow up on and reply to all Quality Assurance internal audits within the allowed timeframe, including taking corrective action where necessary.
  • Assign corrective actions to appropriate personnel.
  • Ensure completion of corrective actions and maintain the required standard.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.